You are here: Industry Insights > COVID-19

News List

TCM provides new alternatives for the fight against COVID-19 prnasia
December 22, 2021
A news report by haiwainet.cn: During the 18th World Congress of Traditional Chinese Medicine held on 4 December 2021, experts from Spain...
COVID-19 vaccine protection wanes after three months, study suggests WorldPharmaNews
December 22, 2021
The protection offered by the Oxford-Astra Zeneca COVID-19 vaccine declines after three months of receiving two doses, a study says.
EMA recommends GSK’s Xevudy for the treatment of COVID-19 EuropeanPharmaceuticalReview
December 22, 2021
The EMA has recommended granting marketing authorisation for the use of Xevudy (sotrovimab) to treat COVID-19 in adults and adolescents.
Sputnik V due to submit vaccine data to WHO this month expresspharma
December 22, 2021
Moscow rushed to approve the shot for domestic use last year and it has been exported to countries around the world, but it has still not been certified by either the WHO or the EMA...
FDA Approves Pfizer Pill as First At-Home COVID-19 Treatment drugs
December 22, 2021
The U.S. Food and Drug Administration on Wednesday approved the emergency use of the new Pfizer antiviral pill Paxlovid in people who are at high risk for severe COVID-19.
Curia Launches Comprehensive mRNA Offering contractpharma
December 22, 2021
mRNA services combine experience and capabilities from discovery through fill-finish manufacturing.
Pfizer to provide UK with additional 2.5 treatment courses of Paxlovid pharmatimes
December 22, 2021
With authorisation, Pfizer’s oral antiviral candidate Paxlovid is an investigational SARS-CoV-2 protease inhibitor could be prescribed at the first sign of COVID-19 infection.
FDA Grants Emergency Use Authorization for Pfizer's Paxlovid Pill as First At-Home COVID-19 Treatment drugs
December 22, 2021
he U.S. Food and Drug Administration on Wednesday approved the emergency use of Pfizer's new antiviral pill Paxlovid in people who are at high risk for severe COVID-19. It's the first approved treatment for COVID-19 meant to be taken at home.
WellCare of North Carolina Announces "Count on Me" COVID-19 Vaccine Incentive Campaign prnewswire
December 21, 2021
As the holidays near, along with the first detection of the omicron variant in North Carolina, WellCare of North Carolina is launching a COVID-19 vaccine member incentive program to encourage its Medicaid members to get vaccinated.
CytoSorbents Announces Publication of U.S. CTC Multicenter Registry Results Using CytoSorb? in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO) prnewswire
December 21, 2021
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology...